CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA- identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies

British Journal of Haematology

Volumn 108, Issue 2, 2000, Pages 408-414

  Bahçeci, Erkut ^a   Read, Elizabeth J ^b   Leitman, Susan ^b   Childs, Richard ^a   Dunbar, Cynthia ^a   Young, Neal S ^a   Barrett, A John ^a,c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Allogeneic stem cell transplantation; CD34+ cells; Haematological malignancy

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD34; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 0034099070     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01838.x     Document Type: Article

References (23)

1. Apperley, J.F., Jones, L., Hale, G., Goldman, J.M. & Galton, D.G. (1986) Bone marrow transplantation for chronic myeloid leukemia: T cell depletion with Campath-1 reduces the incidence of acute graft-versus-host disease but may increase the risk of leukemic relapse. Bone Marrow Transplantation, 1, 53-66.
2. Aversa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Iacucci, R., Zei, T., Martelli, M.P. & Gambelunghe, C. (1994) Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood, 84, 3948-3955.
3. Bacigalupo, A., Zikos, P., Van Lint, M.T., Valbonesi, M., Lamparelli, T., Gualandi, F., Occhini, D., Mordini, N., Bregante, S., Berisso, G., Vitale, V., Sessarego, M. & Marmont, A.M. (1998) Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience. Experimental Hematology, 26, 409-414.
4. Barrett, A.J., Mavroudis, D., Tisdale, J., Molldrem, J., Clave, E., Dunbar, C., Cottler-Fox, M., Phang, S., Carter, C., Okunnieff, P., Young, N.S. & Read, E.J. (1998) T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect. Bone Marrow Transplantation, 21, 543-551.
5. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chouncey, T., Storb, B. & Buckner, C.D. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825-831.
6. Bensinger, W., Appelbaum, F., Rowley, S., Storb, B., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Reginald, C., Chouncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R.P. & Buckner, C. (1995) Factors that influence collection and engraftment of autologous peripheral blood stem cells. Journal of Clinical Oncology, 13, 2547-2555.
7. Bensinger, W.I., Clift, R., Martin, P., Appelbaum, F.R., Demirer, T., Gooley, T., Lilleby, K., Rowley, S., Sanders, J., Storb, R. & Buckner, C.D. (1996) Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 88, 2794-3800.
8. Butturini, A. & Gale, R.P. (1988) T-cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplantation, 3, 185-192.
9. Cottler-Fox, M., Cipolone, K., Yu, M., Berenson, R., O'Shaughnessy, J. & Dunbar, C. (1995) Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Experimental Hematology, 23, 320-322.
10. Couriel, D., Canosa, J., Engler, H., Collins, A., Dunbar, C. & Barrett, J. (1996) Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplantation, 18, 347-353.
11. Hartung, G., Uharek, L., Zeis, M., Glass, B., Steinmann, J., Dreger, P., Kronke, M. & Schimitz, N. (1998) Superior antileukemic activity of murine peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and stem cell factor (SCF) as compared to G-CSF alone. Bone Marrow Transplantation, 21, S16-S20.
12. Johnson, B.D., Drobyski, WR. & Truitt, R.L. (1993) Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplantation, 11, 329-336.
13. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
14. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S. & Bortin, M. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120-2130.
15. Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C. & Barrett, J. (1996) CD34+ cell dose predicts survival, posttransplant morbidity and rate of hematological recovery after allogeneic marrow transplants for hematologic malignancies. Blood, 88, 3223-3229.
16. Noga, S.J., Seber, A., Davis, J.M., Berenson, R.J., Vogelsang, G.B., Braine, H.G., Hess, A.D., Marcellus, D., Miller, C.A., Sharkis, S.J., Goodman, S.N., Santos, G.W. & Jones, R.J. (1998) CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment. Journal of Hematotherapy, 7, 151-157.
17. Peto, R. & Peto, J. (1972) Asymptotically efficient rank invariant procedures. Journal of the Royal Statistical Society, 135, 185-194.
18. Prentice, H.G., Gluckman, E., Powles, R., Ljungman, P., Milpied, N.J., Fernandez-Rañada, J.M., Mandelli, F., Kho, P., Kennedy, L. & Bell, A.R. for the European Acyclovir for CMV Prophylaxis Study Group. (1994) Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet, 343, 749-753.
19. Reisner, Y. & Martelli, M.F. (1995) Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunology Today, 16, 437-440.
20. Ringden, O. & Ringden, O. (1985) Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation, 40, 39-44.
21. Roscoe, R.A., Rybka, W., Winkelstein, A., Housto, A.M. & Kiss, J.E. (1994) Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry, 16, 74-79.
22. Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M. & Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 4226-4235.
23. Weaver, C., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L. & West, W. (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood, 86, 3961-3969.